The Hoffman ALS Clinical Trial Awards Program supports researchers conducting biomarker-driven early trials of ALS therapies and imaging tracers to advance treatment development and care.
Award for Early Career Investigators in Clinical Studies in ALS supports early career researchers conducting clinical studies in ALS, recognizing good research and encouraging their work in the field.
The Lawrence and Isabel Barnett Drug Development Program supports academic and industry investigators conducting preclinical studies of new or repurposed ALS therapies to advance them toward clinical testing.
Longitude Prize on ALS supports multidisciplinary teams using AI to discover, prioritise and validate therapeutic targets, seeking the strongest evidence of potential to advance ALS treatment.
The CReATe Consortium and American Brain Foundation Young Investigator Award funds early-career clinical research on ALS and related neurodegenerative diseases, in collaboration with the American Academy of Neurology.
NIH plans to support research using data from expanded access protocols that provide investigational treatments to people with ALS; applications are not yet being solicited.